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Neural network involving medial orbitofrontal cortex 
and dorsal periaqueductal gray regulation in human 
alcohol abuse
Tianye Jia1,2,3*†, Chao Xie1,2*, Tobias Banaschewski4, Gareth J. Barker5, Arun L. W. Bokde6, 
Christian Büchel7, Erin Burke Quinlan3, Sylvane Desrivières3, Herta Flor8,9, Antoine Grigis10, 
Hugh Garavan11, Penny Gowland12, Andreas Heinz13, Bernd Ittermann14, Jean-Luc Martinot15, 
Marie-Laure Paillère Martinot15,16, Frauke Nees4,8,17, Dimitri Papadopoulos Orfanos10, 
Luise Poustka18, Juliane H. Fröhner19, Michael N. Smolka19, Henrik Walter13, Robert Whelan20, 
Gunter Schumann1,21,22,23, Trevor W. Robbins1,24†, Jianfeng Feng1,2,25,26,27†, IMAGEN Consortium‡
Prompted by recent evidence of neural circuitry in rodent models, functional magnetic resonance imaging and 
functional connectivity analyses were conducted for a large adolescent population at two ages, together with 
alcohol abuse measures, to characterize a neural network that may underlie the onset of alcoholism. A network 
centered on the medial orbitofrontal cortex (mOFC), as well as including the dorsal periaqueductal gray (dPAG), 
central nucleus of the amygdala, and nucleus accumbens, was identified, consistent with the rodent models, with 
evidence of both inhibitory and excitatory coregulation by the mOFC over the dPAG. Furthermore, significant 
relationships were detected between raised baseline excitatory coregulation in this network and impulsivity 
measures, supporting a role for negative urgency in alcohol dependence.
INTRODUCTION
Alcohol use disorder (AUD) is a highly prevalent mental disorder 
characterized by harmful alcohol use (alcohol abuse) and alcohol 
dependence, according to both Diagnostic and Statistical Manual 
of Mental Disorders, 5th Edition (DSM5) (1) and International 
Classification of Diseases 11th Revision (ICD-11) (2) criteria. Hazard-
ous alcohol use, e.g., binge drinking behavior, has been proposed as 
a risk factor for future AUD diagnosis (2–4). Multiple neurobiological 
mechanisms have been proposed for AUD, with particular empha-
ses on reward-related, limbic, and prefrontal cortical regions (5).
Recently, modern neurobiological techniques, including optoge-
netics, have been used in animal models to elucidate the neural cir-
cuitry underlying possible precursors of alcohol dependence. For 
example, compulsive drinking by mice of alcohol adulterated with 
bitter-tasting quinine was bidirectionally modulated by activity in a 
novel circuitry involving direct projections from the medial pre-
frontal cortex (mPFC) to the brainstem dorsal periaqueductal gray 
(dPAG) (6), a region regulating both passive “freezing” versus ac-
tive escape behaviors depending on the strength of aversive signals 
(7–10). According to this model, compulsive drinking arises be-
cause of a reduction in the influence of the mPFC and consequent 
disinhibition of the response to aversive stimuli. By contrast, a second 
study in rats has implicated the central nucleus of the amygdala 
(CeA) (11). Specifically, rats with deficits in the expression of the 
-aminobutyric acid (GABA) transporter GAT-3 preferred alcohol 
over a sweet solution, and animals normally preferring the sweet 
solution switched their preference to alcohol following knockdown 
of GAT-3. Furthermore, selective reductions in GAT-3 expression 
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in the CeA were also found in people dying with AUD (12), helping 
to validate the importance of this murine model.
The question arises, however, of how to integrate these findings 
in the two murine models to define the neural circuitry contribut-
ing to the induction of alcohol dependence. It is well established, for 
example, that the CeA has a strong functional influence on the 
dPAG via its anatomical projections to regulate conditioned freez-
ing behavior (13). Moreover, both the mPFC and the CeA that project 
into basal ganglia circuitry are also implicated in reward-related 
behavior and addiction (14) and are functionally interconnected 
themselves (14). Such broad connectivity between mPFC/orbitofrontal 
cortex (OFC) and subcortical regions has been well established and 
shown to be highly conserved across rodents and primates, includ-
ing humans (15, 16).
To address this key question of translational relevance to human 
alcohol abuse, we analyzed circuitry associated with alcohol abuse 
in the IMAGEN large sample (n = 1890) of adolescents. Previous 
functional magnetic resonance imaging (fMRI) studies in alcohol 
use mainly focused on either resting-state functional connectivities 
(rsFCs) (17–21) or task-based activations (22, 23). For example, 
higher rsFCs involving the OFC have been associated with increased 
(17) and decreased (21) alcohol use in adolescents, whereas task-based 
activations have been almost exclusively of the ventral striatum 
(22, 23). Here, we investigated this circuitry using both task-based 
FC (tbFC) and rsFC with a unified scheme in a longitudinal study, 
at ages 14 and 19 (24). We report that this analysis shows that the 
medial OFC (mOFC) and CeA are both implicated in a network, 
including the dPAG and the nucleus accumbens (NAcc), a structure 
implicated in reward processing.
By also using questionnaire data on the use of alcohol and 
impulsive behavior in this large sample, we were further able to for-
mulate a novel hypothesis suggesting how compulsive drinking may 
arise via activity in this neural network.
RESULTS
Task-based fMRI: Activations and FCs of reward and aversive 
signal processing networks during reward feedback
Nonreward (relative punishment) sensitivity of dPAG, mOFC, 
NAcc, and CeA during reward feedback
In a population of 1890 adolescent participants at age 14, we inves-
tigated the sensitivity to nonreward (i.e., relative punishment) by 
focusing on the “no-win versus large-win” (i.e., receiving an expect-
ed nonreward versus receiving an expected reward) contrast during 
the feedback phase of the monetary incentive delay (MID) task (fig. 
S1), and observed significant activations in the regions of interest 
(ROIs) normally implicated in processing reward-related signals, 
i.e., left mOFC (t = 8.7, Cohen’s D = 0.20, and P < 0.001; Fig. 1) and 
left NAcc (t = 4.84, Cohen’s D = 0.11, and P < 0.001; Fig. 1), and 
those specified for processing aversive signals (such as pain or fear), 
i.e., the dPAG (t = 5.2, Cohen’s D = 0.12, and P < 0.001; Fig. 1) and 
the left CeA (t = 3.85, Cohen’s D = 0.09, and P < 0.001; Fig. 1). Note 
that the ROIs for both dPAG and mOFC were defined on the basis 
of the group-averaged activations with nonreward sensitivity (i.e., 
the activation of no-win versus large-win) t statistics >5.0 during the 
feedback phase of the MID task. As only the left mOFC passed 
the significance threshold, the group-averaged templates for NAcc 
and CeA, derived from previous studies (23, 25), also focused on the 
left hemisphere. Similar nonreward sensitivity was again observed 
for the same task in the same group of individuals at age 19 
(n = 1242) for both dPAG (t = 3.5, Cohen’s D = 0.10, and P < 0.001) 
and left mOFC (t = 7.3, Cohen’s D = 0.21, and P < 0.001), but not 
for the left NAcc (t = 1.1, Cohen’s D = 0.03, and P = 0.23) and left 
CeA (t = 0.1, Cohen’s D = 0.00, and P = 0.91), which might suggest 
developmental changes in function for both NAcc and CeA during 
the reward feedback from ages 14 to 19.
Coregulation of activity within and between networks of reward 
and aversive signal processing
While all four ROIs were found to be activated during the contrast 
of no-win versus large-win at age 14 (n = 1852), we only observed 
significant positive tbFCs consistently across all experimental con-
ditions within either the reward-signal processing network (i.e., be-
tween mOFC and NAcc: Cohen’s D = 0.18, t = 7.89, and P < 0.001 
at no-win; Cohen’s D = 0.27, t = 11.56, and P < 0.001 at small-win; 
Cohen’s D = 0.29, t = 12.40, and P < 0.001 at large-win; Fig. 2) or the 
aversive-signal processing network (i.e., between CeA and dPAG: 
Cohen’s D  =  0.07, t  =  2.86, and P  =  0.064 at no-win; Cohen’s 
D = 0.09, t = 3.78, and P = 0.002 at small-win; Cohen’s D = 0.11, 
t = 4.69, and P < 0.001 at large-win; Fig. 2). We also found signifi-
cant negative tbFCs between these two networks (i.e., between 
mOFC and CeA: Cohen’s D = −0.10, t = −4.52, and P < 0.001 at 
no-win; Cohen’s D = −0.14, t = −5.94, and P < 0.001 at small-win; 
Cohen’s D = −0.15, t = −6.29, and P < 0.001 at large-win; Fig. 2). 
Fig. 1. Masks and MNI coordinates of mOFC, dPAG, CeA and NAcc. The masks 
of mOFC and dPAG were defined on the basis of the group-averaged activation 
(i.e., t statistics >5.0 during the feedback phase of contrast no-win versus large-
win), while the templates for left NAcc and left CeA were derived from previous 
studies (23, 25).
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These results, therefore, might suggest a generally inhibitory regu-
lation between the reward and aversive signal processing networks 
(i.e., with negative tbFC), as well as an excitatory regulation within 
each network (i.e., with positive tbFC). The negative, although non-
significant, tbFCs between mOFC and dPAG (Fig. 2) might represent 
relatively balanced excitatory and inhibitory regulation between 
mPFC and dPAG as observed in mice (6). At age 19, there were 
mostly nonsignificant tbFCs within and between these two networks, 
except for the mOFC-NAcc tbFC (fig. S2), which is likely due to a 
combined effect from both the reduced sample size (i.e., from 1852 
to 1198) and the altered function of both NAcc and CeA during re-
ward feedback, as shown above. All P values above were Bonferroni 
corrected for multiple comparisons (i.e., 3 conditions × 5 tbFCs).
Task-based fMRI: FC of reward and aversive signal 
processing networks during reward feedback and its 
association with alcohol abuse (a human validation of recent 
findings from animal models)
Strengthened mOFC-dPAG inhibition during reward feedback 
relates to higher alcohol abuse at both ages 14 and 19
Figure 3 shows that upon receiving nonreward, individuals with 
higher alcohol abuse scores [the Alcohol Use Disorders Identifica-
tion Test (AUDIT)] showed strengthened negative mOFC-dPAG 
tbFC at age 14 (r = −0.09, n = 1852, t = −4.07, and P < 0.001), as well 
as at age 19 with an even stronger effect size (r = −0.11, n = 1198, 
t = −3.93, and P < 0.001), indicating a consistent underlying inhib-
itory regulation of mOFC over dPAG during no-reward feedback in 
the alcohol abusers, in contrast to the balanced regulation at the 
population level as shown above. Gender and research sites were 
included as control variables throughout the analysis unless other-
wise specified. These findings are all highly consistent with those of 
Siciliano et al. (6), that suppressing mPFC signals to the PAG in 
mice produced compulsive alcohol drinking, and stronger inhibitory 
mPFC-PAG neuron response during early alcohol exposure is an 
early marker for later alcohol abuse. No significant association with 
alcohol abuse score was observed for mOFC-dPAG tbFC under 
both small-win and large-win conditions (table S1). All P values 
above were Bonferroni corrected for multiple comparisons (i.e., 
3 conditions × 5 tbFCs × 2 time points). Despite similar associations 
between mOFC-dPAG tbFCs (upon receiving no-reward) and alco-
hol abuse scores being observed at both ages 14 and 19, as well as the 
small to medium correlation between alcohol abuse scores at both 
ages (r = 0.23, n = 1398, t = 8.72, and P < 0.001), no longitudinal 
correlation was observed between the mOFC-dPAG tbFCs measured 
at both ages (r = −0.01, n = 1032, t = −0.27, and P = 0.789; equiva-
lence test for null effect: P = 0.002 for rL = −0.10 and P < 0.001 for 
rU = 0.10). It is notable that while lower mOFC-dPAG tbFC at age 
14 did show a significant association with higher alcohol abuse scores 
at age 19 (r = −0.052, n = 1198, t = −1.80, and Pone-tailed = 0.036), this 
association was no longer significant when the alcohol abuse score 
at age 14 was controlled (r = −0.031, n = 1198, t = −1.068, and Pone-tailed = 
0.142). These results may therefore indicate that the mOFC-
dPAG tbFC only associates with current alcohol abuse status. In the 
gender-stratified analyses, the associations between higher alcohol 
abuse score and lower mOFC-dPAG tbFCs remained significant in 
both boys and girls separately at both age 14 (r = −0.10, n = 914, 
t = −3.05, and Puncorrected = 0.002  in boys; r = −0.09, n = 938, 
t = −2.71, and Puncorrected = 0.007 in girls) and 19 (r = −0.13, n = 563, 
t = −3.01, and Puncorrected = 0.003  in boys; r = −0.10, n = 635, 
t = −2.63, and Puncorrected = 0.009 in girls), without significant gender 
differences (test for difference between correlations: z =  0.26 and 
P = 0.795 at age 14, and z = 0.50 and P = 0.617 at age 19).
A further investigation into the subcategory of the alcohol abuse 
score from AUDIT showed that at both ages 14 (n = 1852) and 
19 (n = 1198), the mOFC-dPAG tbFC during nonreward feedback 
associated with the indicative “hazardous alcohol use” (e.g., high 
frequency and quantity of alcohol use) (age 14: r = −0.09, t = −3.67, 
and Puncorrected < 0.001, and age 19: r = −0.12, t = −4.16, and 
Puncorrected < 0.001) and “harmful alcohol use” (e.g., alcohol black-
out or injuries due to alcohol abuse) (age 14: r = −0.08, t = −3.56, 
No: D = 0.18, t =  7.89, P < 0.001 
D = 0.27, t = 11.56, P < 0.001 
D = 0.29, t = 12.40, P < 0.001 
Small: 
Large: 
No: D = 0.05, t = 2.16, P = 0.45 
D = 0.04, t = 1.79, P = 1.00
D = 0.04, t = 1.87, P = 0.92
Small: 
Large: 
No: D = 0.04, t = –1.87, P = 0.92
D = 0.09, t = –1.31, P = 1.00
D = 0.11, t = –1.17, P = 1.00
Small: 
Large: 
No: D = 0.04, t = 2.86, P = 0.064
D = 0.09, t = 3.78, P = 0.002Small: 







No: D = –0.10, t = –4.52, P < 0.001
D = –0.14, t = –5.94, P < 0.001Small: 
D = –0.15, t = –6.29, P < 0.001Large: 
All presented P values 
were Bonferroni corrected 




Fig. 2. FCs of reward/aversive signal processing networks at age 14. 







Jia et al., Sci. Adv. 2021; 7 : eabd4074     3 February 2021
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
4 of 10
Puncorrected < 0.001, and age 19: r = −0.09, t = −3.04, and Puncorrected = 0.002), 
whereas the association with severe alcoholic symptoms (i.e., “de-
pendence symptoms”) was only observed at age 19 (r = −0.06, 
t = −2.03, and Puncorrected = 0.043) (table S2). See table S2 for the 
associations of mOFC-dPAG tbFC and each AUDIT subitem.
Weakened mOFC-CeA inhibition during reward feedback 
associated with greater alcohol abuse at age 14 but not 19
Upon receiving nonreward, individuals with higher alcohol abuse 
scores were found with weakened negative (i.e., a larger but still 
negative value) mOFC-CeA tbFC (r = 0.09, t = 3.79, and P < 0.001 
Bonferroni corrected for 3 conditions × 5 FCs × 2 time points) at 
age 14 (n = 1852) (Fig. 3), suggesting that a reduced coregulation 
among mOFC and CeA upon receiving nonreward may contribute 
to alcohol abuse symptoms. This association was primarily observed 
in boys (r = 0.12, n = 914, t = 3.78, and Puncorrected < 0.001) but not 
in girls (r = 0.05, n = 938, t = 1.45, and Puncorrected = 0.148), although 
such a difference was not significant (z = 1.67 and P = 0.095). On 
the other hand, the same associations were practically null at age 19 
(Puncorrected > 0.50; equivalence test for null effect: P < 0.001 for both 
rL = −0.10 and rU = 0.10; Fig. 3), and we also failed to observe any 
association between the mOFC-CeA tbFC at age 14 and future alco-
hol abuse score at age 19 (Puncorrected > 0.80; equivalence test for null 
effect: P < 0.001 for both rL = −0.10 and rU = 0.10). The diminished 
association with alcohol abuse at age 19 was in line with the reduced 
strength of the mOFC-CeA tbFC, as well as the inactivation for the 
corresponding CeA at age 19 as shown above. Further, we observed 
no significant associations between the mOFC-CeA tbFC with alcohol 
abuse at other experimental conditions, i.e., receiving a small or 
large reward, at both ages 14 and 19 (table S1).
A further investigation showed that, at age 14, the mOFC-CeA 
tbFC during nonreward feedback was associated with the indicative 
“hazardous use” (r = 0.07, t = 3.08, and Puncorrected = 0.002), as well 
as with alcoholic “dependence symptoms” (r = 0.05, t = 2.09, and 
Puncorrected = 0.037) and harmful alcohol use (r = 0.09, t = 3.92, and 
Puncorrected < 0.001) (table S2). See table S2 for associations of mOFC-
CeA tbFC with each AUDIT subitem at age 14.
It is notable that the tbFCs of mOFC-dPAG and mOFC-CeA during 
nonreward feedback at age 14 provide nonoverlapping significant contri-
butions to the alcohol abuse score, i.e., remaining significant while mutu-
ally controlling each other in the same linear model (r = −0.09, t = −3.94, 
and P < 0.001 and r = 0.08, t = 3.65, and P < 0.001, respectively) (table 
S3). However, for CeA-dPAG, NAcc- dPAG, and mOFC- NAcc 
tbFCs, we observed no significant association with the alcohol abuse 
score across all reward conditions at both ages 14 and 19 (table S1).
Resting-state fMRI: FC of reward and aversive signal 
processing networks during resting-state and its association 
with alcohol abuse (an exploratory analysis outside 
the reward/punishment context)
Strengthened positive rsFCs among reward and aversive signal 
processing networks relate to greater alcohol abuse
At age 19, there was a strong positive rsFC between each pair of 
ROIs among both networks (minimum Cohen’s D > 0.5, P < 0.001, 
and n = 961; see table S4) during resting-state fMRI. This contrasted 
with the situation during reward feedback where rsFCs among 
reward and aversive signal processing networks were largely non-
significant, except for the mOFC-NAcc rsFC (fig. S2). In addition, 
higher alcohol abuse scores were found in significant association 
with increased strength of three out of five rsFCs (n = 961), i.e., the 
rsFCs linking mOFC with each of NAcc (r = 0.20, t = 6.19, and 
P < 0.001), CeA (r = 0.15, t = 4.65, and P < 0.001), and dPAG 
(r = 0.13, t = 4.06, and P < 0.001) (Fig. 3). These P values were 
corrected for the number of tested FCs. In the gender-stratified 
analyses, all three rsFCs remained significant when tested for asso-
ciations with alcohol abuse scores in boys (n = 447; mOFC-NAcc: 
r = 0.17, t = 3.53, and Puncorrected < 0.001; mOFC-CeA: r = 0.18, 
t = 3.95, and Puncorrected < 0.001; mOFC-dPAG: r = 0.11, t = 2.43, and 
Puncorrected = 0.016) and girls (n = 514; mOFC-NAcc: r = 0.18, t = 4.09, 
and Puncorrected < 0.001; mOFC-CeA: r = 0.11, t = 2.47, and Puncorrected = 
0.014; mOFC-dPAG: r = 0.13, t = 2.91, and Puncorrected = 0.004) sep-
arately, and there are no significant gender differences for these 
associations (mOFC-NAcc: z = −0.19 and P= 0.85; mOFC-CeA: 
z = 0.13 and P = 0.21; mOFC-dPAG: z = −0.2 and P = 0.84).
Further investigation showed that at age 19, the mOFC-related 
rsFCs were all associated with the indicative hazardous use (n = 961) 
(CeA: r = 0.16, t = 4.95, and Puncorrected < 0.001; NAcc: r = 0.20, 
t = 6.29, and Puncorrected < 0.001; and dPAG: r = 0.12, t = 3.72, and 
Puncorrected < 0.001) and harmful alcohol use (CeA: r = 0.09, t = 2.84, 
and Puncorrected < 0.001; NAcc: r = 0.14, t = 4.23, and Puncorrected < 0.001; 










** Signicant at level 0.01
***Signicant at level 0.001
Significance level were Bonferroni corrected for 3 conditions × 5 FCs × 2 time points 
‡Significant mediation effect (uncorrected)
Null/balance regulation between ROIs (see Fig. 2) 
Negative regulation FC between ROIs (see Fig. 2) 






Age 14: r =  –0.09**
Nonreward feedback (ages 14 and 19) Resting state (age 19 only)
Age 19: r =  –0.11**
Age 14: r = 0.09**
Age 19: r =  –0.01
Age 14: r = –0.05




Fig. 3. The summary of the main findings. 
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dependence symptoms (table S5). See table S5 for associations of 
mOFC-CeA, mOFC-NAcc, and mOFC-dPAG rsFCs with each AUDIT 
subitem at age 19.
rsFCs show overlapping contributions to alcohol abuse independent 
of the contribution from tbFC
A further multiple linear model integrating all these rsFCs could 
explain 3.2% variance of alcohol abuse scores at age 19 [adj-
R2 = 0.032, F(5,955) = 7.35, and P < 0.001], where only the mOFC-NAcc 
FC remained significant after controlling for the other rsFCs (r = 0.17, 
t = 3.16, and P = 0.002; table S6A), suggesting a commonly shared 
variance of alcohol abuse scores among all rsFCs, although domi-
nated by the mOFC-NAcc rsFC.
In addition, the tbFC of mOFC-dPAG at age 19, as identified 
above, could explain an additional 1% variance above the rsFCs 
(t = −3.27 and P = 0.001), increasing the total explained variance to 
4.4% [adj-R2 = 0.044, F(6,906) = 7.97, and P < 0.001; table S6B]. 
Therefore, tbFC and rsFC from the reward and aversive signal pro-
cessing networks may contribute independently to alcohol abuse, 
thus representing different underlying neural mechanisms.
Impulsivity partially mediates the associations between rsFCs 
and alcohol abuse
Impulsivity, especially “urgency,” has been consistently proposed as 
a major risk factor for alcohol abuse (26, 27). Collectively, rsFCs 
from mOFC (i.e., mOFC-dPAG, mOFC-NAcc, and mOFC-CeA) 
were found to be in significant associations with the impulsivity total 
score [measured by the temperament and character inventory (TCI)] 
[adj-R2 = 0.009, F(3,947) = 2.65, and P = 0.047], particularly the sub-
item representing urgency: “I like to make quick decisions so I can 
get on with what has to be done” [adj-R2 = 0.009, F(3,947) = 3.89, and 
Puncorrected = 0.009]. All three mOFC-related rsFCs also showed sig-
nificant associations with this item in the corresponding univariate 
analyses (n = 951) (CeA: r = 0.10, t = 2.96, and Puncorrected = 0.003; 
NAcc: r = 0.07, t = 2.10, and Puncorrected = 0.040; dPAG: r = 0.08, 
t = 2.58, and Puncorrected = 0.009). Mediation analyses further suggested 
that the urgency subitem may act as an intermediary variable in the 
link between the mOFC-related rsFCs and the alcohol abuse: mOFC- 
related FCs→impulsivity→AUDIT total score [CeA: proportion 
mediated (Prop.Med.) = 5.3%; 95% confidence interval (CI), 0.01 to 
0.13; and P= 0.014; NAcc: Prop.Med. = 2.6%; 95% CI, 0.001 to 0.07; 
and P = 0.034; dPAG: Prop.Med. = 5.4%; 95% CI, 0.007 to 0.15; and 
P = 0.014; Fig. 3). In contrast, this urgency subitem showed no asso-
ciation with the mOFC-PAG tbFC (nonreward feedback) (r = −0.01, 
n = 1164, t = −0.48, and P = 0.646; equivalence test for null effect: 
P = 0.002 for rL = −0.10 and P < 0.001 for rU = 0.10) at age 19, and 
so did the impulsivity total score (r = 0.02, n = 1164, t = 0.63, and 
P = 0.523; equivalence test for null effect: P < 0.001 for rL = −0.10 
and P = 0.003 for rU = 0.10), suggesting that the mediating role of 
impulsivity was specific to rsFCs.
Impacts of other substance use and psychiatric symptoms 
on relationships of both tbFC and rsFC with alcohol abuse
As alcohol abuse is commonly comorbid with other substance abuse 
and psychiatric disorders, we further investigated whether these 
factors could confound our findings. In the present sample, we first 
confirmed that alcohol abuse scores were highly correlated with other 
substance use (i.e., yearly cannabis use and monthly smoking) and 
common psychiatric symptoms [i.e., depression, anxiety, attention 
deficit hyperactivity disorder (ADHD) symptoms, and conduct prob-
lems] (table S7A).
We then checked for possible associations between the identified 
tbFC and rsFC and the other substance use/psychiatric symptoms, 
and we found the following results: at age 14, neither task-based 
mOFC-CeA FC nor task-based mOFC-dPAG FC was found to be 
strongly associated with other substance use and psychiatric symp-
toms (i.e., all Puncorrected > 0.05; equivalence tests for null effects: 
Pmax = 0.005 for rL = −0.10 and Pmax = 0.003 for rU = 0.10; table S7, 
B and C); at age 19, the tbFC of mOFC-dPAG showed nominally 
significant association with cannabis use (r  =  −0.06, n  =  1193, 
t = −2.04, and Puncorrected = 0.042) and smoking (r = −0.07, n = 1193, 
t = −2.28, and Puncorrected = 0.023) (table S7D). However, neither 
association was significant when controlling for alcohol abuse 
scores (for cannabis use: r = −0.02, t = −0.82, and Puncorrected = 0.418; 
for smoking: r = −0.04, t = −1.28, and Puncorrected = 0.204), suggest-
ing both cannabis use and smoking were secondary to alcohol abuse 
in terms of their associations with the tbFC of mOFC-dPAG. Also, 
at age 19, we found the rsFC of mOFC-NAcc in a nominally signif-
icant association with cannabis use (r = 0.08, n = 956, t = 2.37, and 
Puncorrected = 0.018), ADHD symptoms (r = 0.09, n = 951, t = 2.69, 
and Puncorrected = 0.007), and conduct problems (r = 0.09, n = 951, 
t = 2.63, and Puncorrected = 0.009) (table S7F). Again, these associa-
tions disappeared when controlling for alcohol abuse (for cannabis 
use: r = −0.01, n = 956, t = −0.23, and Puncorrected = 0.819; for ADHD 
symptoms: r = 0.05, n = 951, t = 1.59, and Puncorrected = 0.112; for 
conduct problems: r = 0.05, n = 951, t = 1.67, and Puncorrected = 0.097). 
The other two rsFCs had no significant association with the other 
substance use or psychiatric symptoms (table S7, E and G).
Last, after controlling for all of the other substance use and psy-
chiatric symptoms, the significant associations of alcohol abuse 
score with both tbFC and rsFCs remained significant (tbFC mOFC-
dPAG: r = −0.08, n = 1845, t = −3.37, and Puncorrected < 0.001 at age 14, 
and r = −0.08, n = 1051, t = −2.53, and Puncorrected = 0.012 at age 19; 
tbFC mOFC-CeA at age 14: r =  0.08, n = 1845, t =  3.61, and 
Puncorrected < 0.001; rsFC mOFC-dPAG at age 19: r = 0.13, n = 856, 
t = 3.96, and Puncorrected < 0.001; rsFC mOFC-CeA at age 19: r = 0.14, 
n = 856, t = 4.09, and Puncorrected < 0.001; rsFC mOFC-NAcc at age 19: 
r = 0.16, n = 856, t = 4.63, and Puncorrected < 0.001; also, see table S8 
for more detailed results with AUDIT subcategories and items). 
Therefore, the above results indicate not only that the observed 
associations between tbFC and rsFC and alcohol abuse score were 
unlikely due to other confounding factors, such as substance abuse 
and psychiatric disorders, but also that these FCs were highly spe-
cific for alcohol abuse rather than abuse of other substances.
DISCUSSION
Analysis of FC in two neuroimaging modalities, task-based fMRI 
using the monetary delayed incentive task and resting-state fMRI, 
in a large population of human adolescents, was used successfully to 
support the neural validity of two distinct rodent models of AUD. In 
addition, further analysis revealed a possible role for impulsivity in 
causal mediation of the link with self-reported measures of alcohol 
abuse.
At age 14, we identified that mOFC upon receiving nonreward 
(relative punishment) regulates adolescent alcohol abuse via two 
distinct pathways: (i) an mOFC-dPAG tbFC inhibitory pathway 
involved in regulating the transmission of punishment signals, the 
inhibition of which was proposed to facilitate compulsive drinking 
behavior (6); (ii) an mOFC-CeA tbFC pathway involved in processing 
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negative emotion (11), in which greater negative emotion perception 
during no-reward feedback is linked to higher alcohol consumption.
At age 19, however, only the mOFC-dPAG tbFC inhibitory path-
way remained significant, and the mOFC-CeA tbFC pathway was 
muted, potentially due to the significantly reduced tbFC strength at 
age 19 (t = −2.11, n = 1032, and P = 0.035). In addition, the same 
mOFC-dPAG FC during resting state was also identified to be in 
significant association with alcohol abuse, although in the opposite 
direction. These results, therefore, might suggest two independent 
regulatory pathways between mOFC and dPAG contributing to alco-
hol abuse, excitatory regulation during resting state, and inhibitory 
regulation upon receiving nonreward (relative punishment), given 
the observation that both excitatory and inhibitory neurons project 
from mPFC/mOFC to dPAG (6, 10). While inhibiting transmission 
of punishment information to dPAG (i.e., aborting bottom-up reg-
ulation) plays a central role in the reduced sensitivity to the punish-
ment that further leads to compulsive alcohol use, as suggested by 
Siciliano et al. (6), dPAG has also been found to have a top-down 
regulatory role in thresholding and initiating “escape” behavior by 
regulating its vigor and reaction time (7–9). Therefore, the excitato-
ry regulation of mOFC over dPAG during resting state, which is not 
subject to a specific stimulus, may serve as an example of top-down 
regulation. Stronger coregulation between mOFC and dPAG during 
the resting state may indicate an elevated baseline excitation of 
dPAG neurons, which could not only produce persistent aversive 
signals but also lower the threshold of external stimuli to initiate 
escape behavior. The combination of both may cause impulsive 
responses known as “negative urgency,” a consistently identified 
major risk factor for alcohol abuse (26, 27). This hypothesis was 
supported by the significant mediation effect of the “urgency” item 
over the association between mOFC-dPAG rsFC and alcohol abuse 
(see Fig. 4 as a summary of both pathways). Also, both mOFC-NAcc 
and mOFC-CeA rsFCs may additionally affect alcohol abuse through 
(partly) regulating impulsive behaviors, which largely resemble the 
findings of mOFC-dPAG rsFC, hence suggesting a regulatory net-
work of dPAG with a central focus at mOFC, and input from the 
amygdala and ventral striatum (10). The above findings might echo 
a previous case-control study of alcohol dependence (28) with a rel-
atively small sample size (25 cases and 26 controls), where higher 
rsFCs were observed in the alcohol dependence group. However, 
these authors also found OFC-related rsFCs in negative correlations 
with negative urgency in the alcohol dependence group, in contrast 
to our finding that stronger OFC-related rsFCs were related to higher 
urgency, which is more consistent with the positive behavioral cor-
relation between negative urgency and alcohol dependence (26, 27).
To demonstrate these results, it has been necessary to analyze 
data from a large cohort of human adolescents, some of whom are 
at the onset of alcohol abuse, studied longitudinally. While many of 
the findings are highly significant, the amount of variance account-
ed for is inevitably small, indicating that many other factors, other 
than, for example, impulsivity and reductions in regulatory control 
over aversive processing, likely contribute to drinking in this popula-
tion (29). The interpretation of the contrasting findings for the task-
based and resting-state mOFC-dPAG FCs in relation to self-reported 
alcohol abuse in terms of an altered excitatory-inhibitory balance of 
mOFC outflow to the dPAG is hypothetical and requires further 
confirmation, but is consistent with our functional interpretation.
We further showed that common confounding factors, such as 
gender, other substance use, and psychiatric problems, have negli-
gible impacts on the associations of both tbFC and rsFC with alcohol 
abuse. Also, while some FCs did show weak associations with other 
substance use or psychiatric problems, these associations did not 
survive after controlling for alcohol abuse. Together, these results 
suggested both tbFC and rsFC connecting mOFC to subcortical re-
gions, i.e., NAcc, CeA, and dPAG, were highly specific for alcohol 
abuse rather than abuse of other substances. In line with this, while 
previous studies have shown that brain-wide increased rsFCs were 
correlated with higher alcohol use but lower smoking (17), such a 
phenomenon was not observed in either rsFC or tbFCs among our 
targeted ROIs. However, we also noted that other substance use, 
notably of tobacco and cannabis, was only moderate in the present 
cohort (Table 1), and hence, our findings might not be directly 
translated to cohorts with more severe other substance use. None-
theless, our findings therefore probably relate more specifically to 
alcohol abuse. In addition, while the previous literature has found 
anticorrelations between the rsFC of mOFC-CeA and both the 
current and future alcohol use in adolescents (21, 30), our findings 
instead indicate a positive correlation. Last, we concede that our 
findings were unable to predict future alcohol abuse, even though 
the same tbFC of mOFC-dPAG was found in association with alco-
hol abuse at both ages 14 and 19.
 In summary, we report evidence that mOFC-dPAG activity is 
linked to alcohol abuse in humans, in line with the observation in 
mice, indicating that the findings in a mouse calcium imaging and 
optogenetic study of adulterated alcohol drinking (6) have relevance 
for human alcohol abuse. The current study highlighted the mOFC 
in humans rather than the agranular mPFC in mice, which is a 
possible limitation in any homologous comparison; however, both 
primate regions are intimately implicated in the medial visceromotor 
network (31). Moreover, we found that the CeA, which is also im-

















































Fig. 4. Dual pathways of mOFC-PAG regulation that leads to alcohol abuse. 
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as in control over escape behavior mediated by the dPAG (13), is 
also associated with the mOFC network. Hence, a major outcome of 
this study has been to translationally validate the two recent prom-
inent murine studies of compulsive alcohol drinking. A second out-
come has been to identify how different modes of interaction of the 




Two thousand Caucasian adolescents from the IMAGEN project 
were included in the present study, with data collected from eight 
sites across Europe (i.e., France, United Kingdom, Ireland, and 
Germany). The project was approved by all local ethics research 
committees, and informed consent was obtained from participants 
and their parents/guardians. A detailed description of the study 
protocol and data acquisition has been previously published (24). In 
this study, we investigated individuals with matched neuroimaging 
and behavior data at baseline (age 14, n = 1890) and the follow-up 
(age 19, n = 1242).
Measurement of alcohol abuse and impulsive behaviors
The alcohol abuse behavior of the IMAGEN participants was as-
sessed using the screening questions from the AUDIT (3). The AUDIT 
was developed by the World Health Organization as a simple way 
to screen and identify people who are at risk of developing al-
cohol problems. The AUDIT test focuses on identifying the prelim-
inary signs of hazardous drinking, mild dependence, and harmful 
alcohol use (table S2). It is used to detect alcohol problems experi-
enced within the last year. Individuals were flagged with “alcohol 
abuse” if they scored more than 7 on the total score of AUDIT. It is 
one of the most accurate alcohol screening tests available (32). The 
measurement of impulsive behavior was conducted through the 
TCI (33), which provides a reliable and meaningful description of 
individual personality.
Measurement of other substance use and psychiatric 
symptoms
The measurements of substance use of the IMAGEN participants 
were based on the European School Survey Project on Alcohol and 
Other Drugs (ESPAD; http://espad.org/), one of the largest cross-
national research projects on adolescent substance use in the world. 
In the present study, we focused on two substance use behaviors: 
smoking and cannabis use. Smoking behavior was measured as the 
frequency during the last 30 days (How frequently have you smoked 
cigarettes during the LAST 30 DAYS, cigarettes per day?), and cannabis 
use was measured as the quantity of marijuana or hashish in the last 
year [How many occasions OVER THE LAST 12 MONTHS have 
you used marijuana (grass and pot) or hashish (hash and hash oil)?].
Table 1. Characteristics of the study population from the IMAGEN cohort. Individuals were flagged with “alcohol abuse” if they scored more than 7 on the 
total score of AUDIT (Alcohol Use Disorders Identification Test); individuals were flagged with “tobacco user” if they self-reported as smoking on a daily basis 
and “cannabis user” if they had at least one of either marijuana or hashish in the last year from the ESPAD (European School Survey Project on Alcohol and 
Other Drugs); individuals were flagged as “anxiety” or “depression” if they scored more than 4 (i.e., very likely) in the corresponding disorder bands (compatible 
with ICD-10 or DSM4) on the basis of DAWBA (Development and Well-Being Assessment); individuals were flagged with high risk for “ADHD” (attention deficit 
hyperactivity disorder) or “conduct disorder” if they scored 7 and more for the hyperactivity score or scored 4 and more for the conduct problems score in 
self-reported SDQ (Strengths and Difficulties Questionnaire), respectively; smoking behavior was measured as the frequency (i.e., cigarettes per day) of smoking 
during the last 30 days, and cannabis use was measured as the number of times using either marijuana or hashish in the last year from the ESPAD. The mean 
values of quantitative measurements were calculated on the basis of the full sample. 
Characteristic measurement Baseline, age 14 (N = 1890) Two-year follow-up, age 19 (N = 1198)
Dichotomized 
measurements n % n %
Male 931 49.3 590 47.5
Alcohol abuse (AUDIT) 50 2.7 292 26.1
Tobacco user (ESPAD) 141 7.5 324 27.0
Cannabis user (ESPAD) 110 5.8 469 39.2
Depression (DAWBA) 22 1.1 42 3.9
Anxiety (DAWBA) 16 0.8 17 1.6
ADHD (SDQ) 240 12.8 97 8.1
Conduct disorder (SDQ) 146 7.8 39 3.2
Quantitative measurements Mean SD Mean SD
AUDIT total score 1.34 2.13 5.55 3.37
Hazardous use 1.08 1.53 4.54 2.33
Dependence symptoms 0.11 0.58 0.43 0.92
Harmful alcohol use 0.26 0.85 1.01 1.50
Impulsivity total score (TCI) 27.03 3.94 24.62 5.42
Smoking per day (ESPAD) 0.29 1.48 1.85 3.95
Cannabis use yearly (ESPAD) 0.59 3.88 6.72 12.74
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The depression and anxiety symptoms of the IMAGEN participants 
were assessed with the Development and Well-Being Assessment 
(DAWBA) (34), which is a wide-ranging psychiatric screening 
questionnaire and has previously been used to define subthreshold 
clinical symptoms in neuroimaging studies of subclinical psychopa-
thology (35). The participants were flagged as “anxiety” or “depression” 
if they scored more than 4 (i.e., very likely) in the corresponding 
disorder bands (compatible with ICD-10 or DSM4) based on DAWBA. 
The symptoms of ADHD and conduct disorder were assessed with 
the self-reported hyperactivity score and conduct problems score, 
respectively, from the Strengths and Difficulties Questionnaire (SDQ) 
(34). The self-reported SDQ was used for both ADHD and conduct 
disorders because it is the only available questionnaire/assessment 
that could provide consistent investigations at both ages 14 and 19. 
The participants were labeled as high risk for ADHD or conduct 
disorder if they scored 7 and more for the hyperactivity score or 4 
and more for conduct problems score.
MID task
Participants performed a modified version of the MID task to ex-
amine neural responses to reward anticipation and reward outcome 
(36). The task consisted of 66 10-s trials. In each trial, participants 
were presented with one of three cue shapes (cue, 250 ms), denoting 
whether a target (white square) would subsequently appear on the 
left or right side of the screen and whether 0, 2, or 10 points could 
be won in that trial. After a variable delay (4000 to 4500 ms) of fix-
ation on a white crosshair, participants were instructed to respond 
with left/right button press as soon as the target appeared. Feedback 
on whether and how many points were won during the trial was 
presented for 1450 ms after the response. With a tracking algo-
rithm, task difficulty (i.e., target duration varied between 100 and 
300 ms) was individually adjusted, such that each participant suc-
cessfully responded on ~66% of trials. Participants had first com-
pleted a practice session outside the scanner (~5 min), during which 
they were instructed that for every 5 points won, they would then 
receive one food snack in the form of small chocolate candies at age 
14 or a small amount of cash at age 19. The current study focused on task 
conditions during the feedback phase and consisted of only hit trials 
where the participants successfully hit the target before it disappeared.
fMRI data acquisition and preprocessing
Image acquisition
Functional MRI data were acquired at eight IMAGEN assessment 
sites with 3-T MRI scanners of different manufacturers (Siemens, Philips, 
General Electric, Bruker). The scanning variables were specifically 
chosen to be compatible with all scanners. The same scanning protocol 
was used in all sites. In brief, high-resolution T1-weighted three- 
dimensional structural images were acquired for anatomical local-
ization and coregistration with the functional time series. Blood 
oxygen level–dependent (BOLD) functional images were acquired 
with gradient-echo, echo-planar imaging (EPI) sequence. For any 
tasks, 300 volumes were acquired for each participant, and each 
volume consisted of 40 slices aligned to the anterior commission/
posterior commission line (2.4-mm slice thickness and 1-mm gap). 
The echo time (TE) was optimized [TE = 30 ms, repetition time 
(TR) = 2200 ms] to provide reliable imaging of subcortical areas.
Task-based functional image preprocessing
Task-based functional MRI data were first analyzed with SPM12 
(Statistical Parametric Mapping, http://fil.ion.ucl.ac.uk/spm). Spatial 
preprocessing included the following: slice time correction to adjust 
for time differences due to multislice imaging acquisition, realignment 
to the first volume in line, nonlinearly warping to the Montreal 
Neurological Institute (MNI) space [based on a custom EPI template 
(53 × 63 × 46 voxels) created out of an average of the mean images 
of 400 adolescents], resampling at a resolution of 3 × 3 × 3mm3, 
and smoothing with an isotropic Gaussian kernel of 5-mm full-width 
at half-maximum (FWHM).
Resting-state functional image preprocessing
The resting-state image was processed with suggested protocols from 
Functional Magnetic Resonance Imaging of the Brain (FMRIB’s) 
Software Library (FSL v5.0.9) and Advanced Normalization Tools 
(ANTs v1.9.2): Motion correction was carried out by applying a 
rigid-body registration of each volume to the middle volume (FSL 
MCFLIRT); nonbrain tissue was removed (FSL BET); and spatial 
smoothing was applied using a 4-mm FWHM Gaussian kernel. In-
dependent component analysis (FSL MELODIC) was run for each 
dataset. Artifact components were identified using an automatic classi-
fication algorithm and subsequently regressed out from the data 
(ICA-AROMA v0.3) (37). The hence cleaned data were then detrended, 
up to a third-degree polynomial, coregistered to a high-resolution 
T1 image [the Boundary-Based Registration (BBR) algorithm used 
by FSL FLIRT], and normalized to 2-mm isotropic MNI standard 
space (ANTs). At last, the preprocessed and normalized resting-state 
data were resliced to 3-mm isotropic voxels. With the preprocessed 
data, we calculated Pearson correlations between the extracted 
mean time courses of provided ROI masks, of which the Fisher 
z-transformation was applied to calculate the rsFCs.
Activation and FC of task-based fMRI
At the first-level analysis, the BOLD signal for each subject was 
assessed by a linear combination of 12 regressors for experimental 
conditions, i.e., 2 targets (hit and miss) × 2 phases (anticipation and 
feedback) × 3 reward magnitudes (no-win, small-win, and large-win), 
where the regressor modeling each of the experimental conditions 
was established by convolving the corresponding experimental con-
dition with SPM’s canonical hemodynamic response function. The 
final general linear model (GLM) contained 12 task-condition re-
gressors and 21 covariate regressors consisting of 12 motion regres-
sors (3 translations, 3 rotations, 3 translations shifted 1 TR before, 
and 3 translations shifted 1 TR later) and 9 additional columns cor-
responding to the long-term effects of the movement [3 nuisance 
variables for the white matter and 6 nuisance variables for ventri-
cles, and commonly referred to as CompCor correction (38)]. These 
regressors were used with the SPM to estimate the condition-specific 
brain activation, i.e., the regression coefficient of the corresponding 
task-condition regressor in the GLM.
The CONN toolbox (39) (version 16.h) was used to estimate the 
condition-specific FC (i.e., no-win, small-win, and large-win) with 
the weighted GLM (wGLM) method. Twelve task-condition regres-
sors and 21 covariate regressors derived above were first regressed 
out from the raw BOLD signal of each ROI, and the residual signals 
were further fed into wGLMs to investigate conditional time series 
correlations (i.e., the conditional FC) between any pairs of ROIs, 
where the temporal weight function for each condition was calculated 
as the corresponding but now rectified task-condition regressor 
(i.e., only time points expected with positive BOLD signals count). 
This approach amplifies the expected hemodynamic delay to 
each task condition and deweights the initial and final scans when 
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estimating functional correlation measures to avoid spurious jumps in 
BOLD signals, as well as reducing the potential cross-talk between 
adjacent task conditions (39). Following the above procedure, ROI-
to-ROI conditional FCs were established, where the group-averaged 
mask templates of ROIs were obtained either from the above activa-
tion analyses (i.e., dPAG and mOFC) or based on previous studies 
(i.e., CeA and NAcc) (23, 25).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/6/eabd4074/DC1
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